ChemicalBook > Product Catalog > Analytical Chemistry > Standard > Pharmaceutical Impurity Reference Standards > N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine Basic information
- Product Name:
- N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- Synonyms:
-
- N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- Tofacitinib Impurity 130
- N-((3R,4S)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (Tofacitinib Impurity）
- 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3R,4S)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-
- Tofatinib Impurity 22
- CAS:
- 1092578-45-4
- MF:
- C20H25N5
- MW:
- 335.45
- Mol File:
- 1092578-45-4.mol
More
Less
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine Chemical Properties
- Melting point:
- 75-77 °C
- Density
- 1.205±0.06 g/cm3(Predicted)
- pka
- 13.36±0.50(Predicted)
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amineSupplier
Hubei Yangxin Medical Technology Co., Ltd.
- Tel
- 15374522761
- 3003392093@qq.com
Chengdu Novel Biomedical Co., Ltd.
- Tel
- 028-85255396 18302801538
- cdnovell@163.com
Shenzhen Polymeri Biochemical Technology Co., Ltd.
- Tel
- +86-400-002-6226 +86-13028896684;
- sales@rrkchem.com
Guangzhou Dreampharm Biotechnology Co., Ltd.
- Tel
- 020-36607679 17825480238
- 3008233717@qq.com
Standardpharm Co. Ltd.
- Tel
- 86-714-3992388
- overseasales1@yongstandards.com
More
Less
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine(1092578-45-4)Related Product Information
- 4-(Hydroxyamino)-4-oxobutanoic acid
- CYANOACETIC ACID-OSU
- N-Hydroxysuccinimide
- Tofacitinib Impurity 2
- Ethyl S-4-chloro-3-hydroxybutyrate
- 2-amino-4-fluoro-5-nitrobenzoic acid
- TF-A
- (3R,4R)-N,4-dimethyl-piperidin-3-amine
- (3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile
- (S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine
- Tofacitinib Impurity 20
- R-afatinib
- 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
- 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
- 3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
- Tofacitinib Impurity 19
- 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile
- (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine